PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:46 AM ET

Sponsor Check › Person

AG
No photo found yet (own website and image search run after this page is viewed)

Arjun Goyal

Named as an officer, director or promoter on SEC Form D filings · CA · Nov 3, 2021 → May 25, 2023

2deals (issuers)
$140Mreported sold
26investors
4Form D filings
2021–2023years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:50 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Arjun Goyal is listed as a director on 4 SEC Form D filings by 2 issuers between Nov 2021 and May 2023: Quanta Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2021–2023; $76.2M reported sold to 17 investors) and Alterome Therapeutics, Inc. (San Marcos, CA — biotechnology — 2022; $63.8M reported sold to 9 investors).

What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $140M sold in total.

Listed alongside Cameron Pitt (3 shared filings), Maha Katabi (3 shared filings), Maria Fardis (3 shared filings), Perry Nisen (3 shared filings), Samuel Saks (3 shared filings) and 6 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Arjun. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 4 public filings for Arjun Goyal and found 4 differences, 1 worth asking the sponsor about: Arjun Goyal is no longer listed on the Jun 24, 2026 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Arjun Goyal has not run yet — it is joining a line of 27,017 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:50 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Arjun Goyal..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:50 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

4 differences found between the filings for Arjun Goyal — 1 worth asking about (compared 4 filings on Oct 24, 2026)

Note · Oct 20, 2021 – Nov 3, 2021

No amendment in the last 12 months on an offering that may still be open — Quanta Therapeutics, Inc. (latest filing Nov 3, 2021)

The latest filing for this offering is dated Nov 3, 2021 (first sale Oct 20, 2021). It reports $40,152,323 sold of $70,152,314 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Worth asking · May 25, 2023 – Jun 24, 2026

Arjun Goyal is no longer listed on the Jun 24, 2026 amendment — Quanta Therapeutics, Inc.

Arjun Goyal appears on the May 25, 2023 Form D (director) but not on the Jun 24, 2026 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · May 25, 2023 – Jun 24, 2026

Offering amount changed between filings — Quanta Therapeutics, Inc.

The May 25, 2023 filing says $54,999,988 offered; the Jun 24, 2026 Form D/A says $89,098,282.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Dec 6, 2017 – Jan 22, 2026

Same name, different state: "Arjun Goyal" (MA or PA) is a separate record

This page covers filings where the address state is CA. A separate record, "Arjun Goyal" with address state MA or PA, is listed on 11 filings — most recently by Vianti Capital Fund I, L.P. (Jan 22, 2026). Both records have filings in the same period (Nov 3, 2021 to May 25, 2023).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 4 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
May 25, 2023 D
Quanta Therapeutics, Inc.
File 021-482575
$0$0$0None listed on this filingEDGAR ↗
Feb 17, 2023 D
Quanta Therapeutics, Inc.
File 021-473779
$0$0$0None listed on this filingEDGAR ↗
Jan 14, 2022 D
Alterome Therapeutics, Inc.
File 021-429619
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2021 D
Quanta Therapeutics, Inc.
File 021-419719
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Arjun Goyal on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Quanta Therapeutics, Inc.

South San Francisco, CA · Nov 3, 2021 → May 25, 2023 · 3 filings
  • May 25, 2023 · D · $50,685,368 sold of $54,999,988 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2023 · D · $29,999,993 sold of $29,999,993 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2021 · D · $40,152,323 sold of $70,152,314 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $76.2M from 17 investors (100% of the $55M target) as of the latest filing. Arjun is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Alterome Therapeutics, Inc.

San Marcos, CA · Jan 14, 2022
  • Jan 14, 2022 · D · $63,799,991 sold of $63,799,991 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $63.8M from 9 investors (100% of the $63.8M target) as of the latest filing. Arjun is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Arjun Goyal — MA, PA, 10 issuers, Dec 6, 2017 → Jan 22, 2026 · no shared issuer

People around Arjun 11

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Maha Katabi

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Maha Katabi is on 8 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel Saks

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Pitt

Director, Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

PN
No photo found yet (own website and image search run after this page is viewed)
Person

Perry Nisen

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Maria Fardis

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

YH
No photo found yet (own website and image search run after this page is viewed)
Person

Ying Huang

Director · 2 shared filings (1 issuer)

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Leonardo Faoro

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 1 shared filing (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Thilo Schroeder

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Thilo Schroeder is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Murphy

Executive Officer, Director, Promoter · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Ryan B. Corcoran

Director, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Arjun Goyal. Their page shows their other deals.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Arjun Goyal by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Arjun Goyal is listed on: none on file. No website or social profile named in Alterome Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #168,209 of 374,652 in line (1,325 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Marcos, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Arjun Goyal appears on a new Form D, or when a court case or SEC action is matched to them. See plans →